Tuesday, September 8, 2026
spot_img

Coloplast A/S – Financial Calendar 2025-26

Please see enclosed pdf.

For more information and calendar invitations for upcoming events, please visit: https://www.coloplast.com/investor-relations/events-calendar/

Kind regards,
Investor Relations
Coloplast A/S
Tel. +45 4911 1800

 

For further information, please contact

Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

Kristine Husted Munk
Senior Director, Investor Relations
Tel. +45 4911 1800 / +45 4911 3266
Email: [email protected]

Simone Dyrby Helvind
Senior Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2981
Email: [email protected]

Press and media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: [email protected]

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917

Website
www.coloplast.com

 

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.

Coloplast was founded on passion, ambition, and commitment. We were born from a nurse’s wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life easier for people with intimate healthcare needs. Over decades, we have helped millions of people to live a more independent life and we continue to do so through innovative products and services. Globally, our business areas include Ostomy Care, Continence Care, Voice and Respiratory Care, Wound and Tissue Repair and Interventional Urology.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2025-09.

All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachment

  • 08_2025_Financial Calendar_2025-26

Powered by SlickText.com

Hot this week

Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update

U.S. Food and Drug Administration (“FDA”) Accepted the NDA for AD109, with a...

Elevra Lithium Announces NAL Expansion Pre-Feasibility Study

BRISBANE, Australia, Sept. 08, 2026 (GLOBE NEWSWIRE) --...

Concentrix Strengthens Enterprise Risk and Compliance Capabilities with Acquisition of CastleHill

Expanding one of Concentrix' fastest-growing business lines, as demand...

Daedalus Special Acquisition Corp. Signs Letter of Intent with HUBX Yazılım Hizmetleri Anonim Şirketi

London, United Kingdom, Sept. 08, 2026 (GLOBE NEWSWIRE)...

Topics

spot_img

Related Articles

Popular Categories

spot_img